EU expands CE mark for Agilent assay in NSCLC

2021-07-21

European regulators have given expanded CE mark certification to Agilent Technologies for its PD-L1 IHC 22C3 pharmDx companion diagnostic assay, allowing it to be used on patients with non-small cell lung cancer.

Full story:

AdvaMed SmartBrief

Medical devices, health care information systems and diagnostic products

Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart.